March 29, 2024 Breaking Ground in Alzheimer’s Diagnosis: Simoa® p-Tau 217 Blood Test Receives FDA Breakthrough Device Designation read more
February 13, 2024 CSF p-Tau 205 Emerges as a Biomarker of Tau Pathology in Alzheimer’s Disease read more
November 16, 2023 Utilizing Digital ELISA for Precise Measurement of Brain Biomarkers in Blood read more
November 7, 2023 Publication Review: Unraveling the Role of Plasma GFAP in Parkinson’s Disease read more
September 26, 2023 Unlocking the Potential of Serum Brain-Derived Tau as a Vital Biomarker in Severe Traumatic Brain Injury read more
August 18, 2023 Establishing a Pediatric Reference Range for Serum Neurofilament Light Chain Using Simoa® Technology read more